Dasatinib Use May Be a Novel Risk Factor for Cytomegalovirus (CMV) Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details